Status:
COMPLETED
Private Medicine Retailer-based Trial of Malaria Tests and Conditional Treatment Subsidies Among Patients With Fever
Lead Sponsor:
Clinton Health Access Initiative Inc.
Conditions:
Malaria Falciparum
Eligibility:
All Genders
1+ years
Phase:
PHASE4
Brief Summary
The goal of this study observational study is to test the effect of conditional subsidies for Rapid Diagnostic Tests (RDT) and Artemisinin Combination Therapies (ACT) on improving the management of ma...
Detailed Description
The ultimate goal of the conditional subsidy scheme is to increase the proportion of patients with malaria that receives an artemisinin combination therapy (ACT) at the point of sale. The objective o...
Eligibility Criteria
Inclusion
- Participants who tested in the Private Medicine Retailer and/or purchased antimalarial (s) for themselves.
- Individuals with malaria-like illness must be present at recruitment.
- Older than one year of age.
Exclusion
- Any individual with signs of severe illness requiring immediate referral.
- Individuals who have taken an antimalarial in the last seven days, including for the current illness.
- Patients \<18 years without a parent or legal guardian present.
- Adults who are unable to consent for themselves
Key Trial Info
Start Date :
December 31 2023
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
July 31 2024
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT06928207
Start Date
December 31 2023
End Date
July 31 2024
Last Update
April 15 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Private Medicine Retailers
Igabi and Kajuru LGA, Kaduna State, Nigeria